Recently, traditional Chinese patent medicines and simple preparations abnormal price risk clues have been intensively released in many places, and traditional Chinese patent medicines and simple preparations price governance has developed in depth.
On November 25, Anhui issued the Notice on Notification and Disposal of traditional Chinese patent medicines and simple preparations Price Verification Clues, requiring the involved traditional Chinese patent medicines and simple preparations enterprises to log into the provincial drug trading system from November 25 to 28, 2025 to reduce prices independently. In addition to Anhui, many other places such as Shanxi, Shandong, Inner Mongolia, Tianjin, and Liaoning have recently issued similar notices.
This price governance work covering multiple regions began in July of this year. At that time, there was a document circulating in the industry called "Notification of Medical Price Risk Clues (First Batch)", which was released by the National Healthcare Security Administration to guide enterprises to regulate their pricing behavior. Subsequently, all regions responded positively and carried out the handling of traditional Chinese patent medicines and simple preparations abnormal price risk clues. At present, normalization governance has been basically achieved in many places.
With the deepening of this work, the information disclosure of some provinces and cities continues to increase, and price differences have attracted widespread attention. Taking Tianjin as an example, the daily expenses related to drugs were not yet announced in the governance list released in September this year, but were announced in the list released on November 21. The daily expenses of some drugs were more than a thousand times higher than the minimum daily expenses of the same variety, and the highest was 3042 times, with a significant difference.
Generally speaking, because the ingredients of traditional Chinese patent medicines and simple preparations with the same name may be different, and the quality standards of different enterprises may be different, the price of the same traditional Chinese patent medicines and simple preparations may be different. However, if the name, material selection, dosage form, and quality standards of traditional Chinese patent medicines and simple preparations are the same, there will be a price difference of more than ten times or even dozens of times, indicating that there is obvious price moisture. It is widely believed in the industry that the promotion of traditional Chinese patent medicines and simple preparations price risk management will effectively squeeze the price moisture, and will form a synergistic effect with other price management means to build a long-term price control mechanism.

